Nistal-Nuño Beatriz
Department of Cardiac and Thoracic Anesthesiology, The John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom.
Saudi J Anaesth. 2017 Apr-Jun;11(2):169-176. doi: 10.4103/1658-354X.203011.
Experimental models using short-duration noxious stimuli have led to the concept of preemptive analgesia. Ketorolac, a nonsteroidal anti-inflammatory drug, has been shown to have a postoperative narcotic-sparing effect when given preoperatively and alternatively to not have this effect. This study was undertaken to determine whether a single intravenous (IV) dose of ketorolac would result in decreased postoperative pain and narcotic requirements.
In a double-blind, randomized controlled trial, 48 women undergoing abdominal hysterectomy were studied. Patients in the ketorolac group received 30 mg of IV ketorolac 30 min before surgical incision, while the control group received normal saline. The postoperative analgesia was performed with a continuous infusion of tramadol at 12 mg/h with the possibility of a 10 mg bolus for every 10 min. Pain was assessed using the visual analog scale (VAS), tramadol consumption, and hemodynamic parameters at 0, 1, 2, 4, 8, 12, 16, and 24 h postoperatively. We quantified times to rescue analgesic (morphine), adverse effects, and patient satisfaction.
There were neither significant differences in VAS scores between groups ( > 0.05) nor in the cumulative or incremental consumption of tramadol at any time point ( > 0.05). The time to first requested rescue analgesia was 66.25 ± 38.61 min in the ketorolac group and 65 ± 28.86 min in the control group ( = 0.765). There were no significant differences in systolic blood pressure (BP) between both groups, except at 2 h ( = 0.02) and 4 h ( = 0.045). There were no significant differences in diastolic BP between both groups, except at 4 h ( = 0.013). The respiratory rate showed no differences between groups, except at 8 h ( = 0.017), 16 h ( = 0.011), and 24 h ( = 0.049). These differences were not clinically significant. There were no statistically significant differences between groups in heart rate ( > 0.05).
Preoperative ketorolac neither showed a preemptive analgesic effect nor was it effective as an adjuvant for decreasing opioid requirements or postoperative pain in patients receiving IV analgesia with tramadol after abdominal hysterectomy.
使用短时间伤害性刺激的实验模型引出了超前镇痛的概念。酮咯酸,一种非甾体抗炎药,已被证明术前给药时具有术后节省麻醉剂的作用,但也有研究表明其并无此作用。本研究旨在确定单次静脉注射(IV)酮咯酸是否会降低术后疼痛及麻醉剂需求量。
在一项双盲、随机对照试验中,对48例行腹部子宫切除术的女性患者进行了研究。酮咯酸组患者在手术切口前30分钟接受30毫克静脉注射酮咯酸,而对照组接受生理盐水。术后采用曲马多以12毫克/小时持续输注进行镇痛,每10分钟可追加10毫克推注剂量。分别在术后0、1、2、4、8、12、16和24小时使用视觉模拟量表(VAS)评估疼痛程度、记录曲马多用量及血流动力学参数。我们对使用补救镇痛药(吗啡)的时间、不良反应及患者满意度进行了量化。
两组间VAS评分无显著差异(P>0.05),且在任何时间点曲马多的累积或增量用量也无显著差异(P>0.05)。酮咯酸组首次请求补救镇痛的时间为66.25±38.61分钟,对照组为65±28.86分钟(P=0.765)。两组间收缩压(BP)无显著差异,仅在2小时(P=0.02)和4小时(P=0.045)时除外。两组间舒张压无显著差异,仅在4小时(P=0.013)时除外。呼吸频率在两组间无差异,仅在8小时(P=0.017)、16小时(P=0.011)和24小时(P=0.049)时除外。这些差异无临床意义。两组间心率无统计学显著差异(P>0.05)。
术前使用酮咯酸既未显示出超前镇痛效果,也不能有效辅助减少接受腹部子宫切除术后静脉注射曲马多镇痛患者的阿片类药物需求量或术后疼痛。